BiotechTube
Home/GlycoTherapeutics/Dr. Thomas Boltje
DT

Dr. Thomas Boltje

Scientific Advisor

GlycoTherapeutics

Therapeutic Areas

OncologyInfectious Disease

GlycoTherapeutics Pipeline

DrugIndicationPhase
Undisclosed Glycan-Disruption ProgramOncology (Immunotherapy combination)Pre-clinical

Leadership Team at GlycoTherapeutics

DJ
Dr. Johan Pijnenborg
CEO
ER
Emiel Rossing
Head of Preclinical Development
NE
Nienke Eerden
Project Leader Medicinal Chemistry
DL
Dr. Leendert van den Bos
Head of Business Development
DC
Dr. Christian Büll
Scientific Advisor
View full GlycoTherapeutics profile